Vertex aims to file its application for approval of VX-770 with the European Medicines Agency by the end of this month. The EMA has already granted the company an expedited review for the drug to ...
While there are still stocks with strong technical momentum, market weakness has us looking at stocks poised for downside moves. Stamps.com (STMP) broke down on Wednesday, falling $3.35 to $112.85 on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback